“Smart Drugs” Are Prevalent in The Ivy League
You may even see it at work.
Harvard Business Review reports.
Like It or Not, “Smart Drugs” Are Coming to the Office
You’ve managed the same team for the past five years — then one day you find out that your most successful employee uses cognitive-enhancing drugs on the job.
This scenario may not be hypothetical for long. The unauthorized use of prescription drugs such as the ADHD medications Adderall and Ritalin and the narcolepsy drug Modafinil is now common among American university students. They use these drugs not to escape work and avoid responsibility but to be able to work more and better.
Up to 20% of Ivy League college students have already tried “smart drugs,” so we can expect these pills to feature prominently in organizations (if they don’t already). After all, the pressure to perform is unlikely to disappear the moment students graduate. And senior employees with demanding jobs might find these drugs even more useful than a 19-year-old college kid does. Indeed, a 2012 Royal Society report emphasized that these “enhancements,” along with other technologies for self-enhancement, are likely to have far-reaching implications for the business world.
Like It or Not, “Smart Drugs” Are Coming to the Office (Harvard Business Review)